Hospira Healthcare Corporation v Janssen Inc

Counsel for the Kennedy Trust and Janssen in a patent impeachment and infringement action related to Remicade (infliximab), a biologic treatment for rheumatoid arthritis.  This was the first patent infringement action in Canada relating to a Subsequent Entry Biologic (a generic version of a biologic drug, also referred to as a biosimilar).